Fig. 8From: The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysisForest plot of the meta-analysis showed non-significant difference in total adverse events of CGRP-mAbs compared with placebo. CGRP-mAbs, monoclonal antibodies to CGRP and its receptor; M-H, Mantel-Haenszel; CI, confidence intervalBack to article page